Literature DB >> 26338916

Clinical Outcomes of Patients with Delayed Diagnosis of Spinal Dural Arteriovenous Fistulas.

W Brinjikji1, D M Nasr2, J M Morris3, A A Rabinstein2, G Lanzino4.   

Abstract

BACKGROUND AND
PURPOSE: Spinal dural arteriovenous fistulas are commonly missed on imaging or misdiagnosed as inflammatory or neoplastic processes. We reviewed a consecutive series of spinal dural arteriovenous fistulas referred to our institution that were missed or misdiagnosed on initial imaging and studied the clinical consequences of missing or misdiagnosing the lesion.
MATERIALS AND METHODS: We reviewed spinal dural arteriovenous fistulas diagnosed at our institution between January 1, 2000, and November 1, 2014. A lesion was defined as "misdiagnosed" if initial MR imaging or CT myelography demonstrated characteristic imaging features of spinal dural arteriovenous fistula but the patient was clinically or radiologically misdiagnosed. Outcomes included length of delay of diagnosis, increased disability (increase in mRS or Aminoff motor disability of ≥1 point) between initial imaging evaluation and diagnosis date, and posttreatment disability.
RESULTS: Fifty-three consecutive spinal dural arteriovenous fistulas that were initially misdiagnosed despite having characteristic imaging findings on MR imaging or CT myelography were included in our study. Eight patients (18.9%) underwent spinal angiography before referral, which was interpreted as having negative findings but was either incomplete (6 cases) or retrospectively demonstrated the spinal dural arteriovenous fistulas (2 cases). The median time of delayed diagnosis was 6 months (interquartile range, 2-14 months). Fifty-one patients (96.2%) had increased disability between the initial study, which demonstrated features of a spinal dural arteriovenous fistula, and diagnosis. Thirty-two patients (60.4%) developed a new requirement for a walker or wheelchair. Following treatment, 21 patients (41.2%) had an improvement of 1 point on the mRS or Aminoff motor disability scale.
CONCLUSIONS: Delayed diagnosis of spinal dural arteriovenous fistula with characteristic imaging features results in high rates of additional disability that are often irreversible despite surgical or endovascular treatment of the fistula.
© 2016 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2015        PMID: 26338916      PMCID: PMC7959966          DOI: 10.3174/ajnr.A4504

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  21 in total

1.  Spinal dural arteriovenous fistulas: outcome and prognostic factors.

Authors:  Marco Cenzato; Alberto Debernardi; Roberto Stefini; Giuseppe D'Aliberti; Maurizio Piparo; Giuseppe Talamonti; Matteo Coppini; Pietro Versari
Journal:  Neurosurg Focus       Date:  2012-05       Impact factor: 4.047

2.  Pearls & oy-sters: clues for spinal dural arteriovenous fistulae.

Authors:  A McKeon; E P Lindell; J L D Atkinson; B G Weinshenker; D G Piepgras; S J Pittock
Journal:  Neurology       Date:  2011-01-18       Impact factor: 9.910

3.  Spinal dural arteriovenous fistula.

Authors:  C Amanieu; M Hermier; N Peyron; A Chabrol; G Deiana; L Manera
Journal:  Diagn Interv Imaging       Date:  2014-09       Impact factor: 4.026

4.  Frequency of spinal arteriovenous malformations in patients with unexplained myelopathy.

Authors:  R G Strom; C P Derdeyn; C J Moran; D T Cross; G J Esper; A Mazumdar; M Al-Lozi; G Lopate; A Pestronk
Journal:  Neurology       Date:  2006-03-28       Impact factor: 9.910

5.  Comparison of dynamic contrast-enhanced 3T MR and 64-row multidetector CT angiography for the localization of spinal dural arteriovenous fistulas.

Authors:  S Oda; D Utsunomiya; T Hirai; Y Kai; Y Ohmori; Y Shigematsu; Y Iryo; H Uetani; M Azuma; Y Yamashita
Journal:  AJNR Am J Neuroradiol       Date:  2013-08-01       Impact factor: 3.825

Review 6.  Spinal vascular malformations.

Authors:  Timo Krings; Michael Mull; Joachim M Gilsbach; Armin Thron
Journal:  Eur Radiol       Date:  2004-10-22       Impact factor: 5.315

7.  Complications of spinal cord arteriography: prospective assessment of risk for diagnostic procedures.

Authors:  G Forbes; D A Nichols; C R Jack; D M Ilstrup; D B Kispert; D G Piepgras; D O Wiebers; F Earnest; P L Axley
Journal:  Radiology       Date:  1988-11       Impact factor: 11.105

8.  Spinal dural arteriovenous fistulas: MR and myelographic findings.

Authors:  J R Gilbertson; G M Miller; M S Goldman; W R Marsh
Journal:  AJNR Am J Neuroradiol       Date:  1995 Nov-Dec       Impact factor: 3.825

9.  Multidisciplinary management of spinal dural arteriovenous fistulas: clinical presentation and long-term follow-up in 49 patients.

Authors:  J Marc C Van Dijk; Karel G TerBrugge; Robert A Willinsky; Richard I Farb; M Christopher Wallace
Journal:  Stroke       Date:  2002-06       Impact factor: 7.914

10.  A simple score (AVFS) to identify spinal dural arteriovenous fistula before spinal digital subtraction angiography.

Authors:  Wenjie Cao; Lei Huang; Liang Ge; Gang Lu; Xiaolong Zhang; Qiang Dong
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-08-06       Impact factor: 2.136

View more
  15 in total

1.  Comparison of Time-Resolved and First-Pass Contrast-Enhanced MR Angiography in Pretherapeutic Evaluation of Spinal Dural Arteriovenous Fistulas.

Authors:  S Mathur; A Bharatha; T J Huynh; R I Aviv; S P Symons
Journal:  AJNR Am J Neuroradiol       Date:  2016-11-03       Impact factor: 3.825

2.  First-Pass Contrast-Enhanced MR Angiography in Evaluation of Treated Spinal Arteriovenous Fistulas: Is Catheter Angiography Necessary?

Authors:  S Mathur; S P Symons; T J Huynh; T R Marotta; R I Aviv; A Bharatha
Journal:  AJNR Am J Neuroradiol       Date:  2016-11-03       Impact factor: 3.825

3.  The Hybrid Assistive Limb® intervention for a postoperative patient with spinal dural arteriovenous fistula and chronic spinal cord injury: A case study.

Authors:  Yukiyo Shimizu; Kei Nakai; Hideki Kadone; Shunsuke Yamauchi; Shigeki Kubota; Tomoyuki Ueno; Aiki Marushima; Kayo Hiruta; Ayumu Endo; Hiroaki Kawamoto; Akira Matsumura; Yoshiyuki Sankai; Yasushi Hada; Masashi Yamazaki
Journal:  J Spinal Cord Med       Date:  2017-05-29       Impact factor: 1.985

Review 4.  Spinal Cord Infarcts: Risk Factors, Management, and Prognosis.

Authors:  Deena M Nasr; Alejandro Rabinstein
Journal:  Curr Treat Options Neurol       Date:  2017-08       Impact factor: 3.598

5.  Spinal Dural Arteriovenous Fistula: A Mimic of Demyelinating Disease and Radiculopathy.

Authors:  María Alfaro-Olivera; Ricardo D Otiniano-Sifuentes; Lourdes Simbrón-Ribbeck; Laura Zelada-Ríos; Danny Barrientos-Imán; Carlos Abanto; Jorge Ramírez-Quiñones; Ana Valencia
Journal:  Cureus       Date:  2022-04-14

6.  [Clinical outcomes following microsurgery and endovascular embolization in the management of spinal dural arteriovenous fistula: A meta-analysis study].

Authors:  C W Yuan; Y J Wang; S J Zhang; S L Shen; H Z Duan
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-04-18

7.  Clinical Characteristics and Treatment Outcomes of Spinal Arteriovenous Malformations.

Authors:  Ji Eun Park; Hae-Won Koo; Hairi Liu; Seung Chul Jung; Danbi Park; Dae Chul Suh
Journal:  Clin Neuroradiol       Date:  2016-09-13       Impact factor: 3.649

8.  Unique Gadolinium Enhancement Pattern in Spinal Dural Arteriovenous Fistulas.

Authors:  Nicholas L Zalewski; Alejandro A Rabinstein; Waleed Brinjikji; Timothy J Kaufmann; Deena Nasr; Michael W Ruff; Eoin P Flanagan
Journal:  JAMA Neurol       Date:  2018-12-01       Impact factor: 18.302

9.  Treatment strategy to maximize the treatment outcome of spinal dural arteriovenous fistula after initial endovascular embolization attempt at diagnostic angiography.

Authors:  Heui Seung Lee; Hyun-Seung Kang; Sung Min Kim; Chi Heon Kim; Seung Heon Yang; Moon Hee Han; Chun Kee Chung
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

10.  Hyperbaric oxygen therapy for postoperative spinal dural arterio-venous fistula patients: An observational cohort study.

Authors:  Sichang Chen; Yongjie Ma; Peipeng Liang; Xiaohui Wang; Chao Peng; Lisong Bian; Jiang Liu; Jianzhang Ding; Hongqi Zhang; Feng Ling
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.